Camp4 Therapeutics CORP (CAMP) SEC Filings — 2025

Filings

• Camp4 Therapeutics Corp. Enters and Terminates Agreements — 8-K · Dec 23, 2025
• Camp4 Therapeutics CORP 8-K Filing — 8-K · Dec 18, 2025
• Camp4 Therapeutics Corp. Files 8-K for Material Agreement — 8-K · Dec 18, 2025
• Camp4's Q3 Loss Widens to $15.1M Despite New Collaboration Revenue — 10-Q · Nov 6, 2025
• Camp4 Therapeutics Files 8-K — 8-K · Oct 1, 2025
• Camp4 Therapeutics Files 8-K: Material Agreement, Equity Sales — 8-K · Sep 10, 2025
• Camp4's Losses Persist Amid Rising R&D, Cash Drains — 10-Q · Aug 14, 2025
• Camp4 Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jun 13, 2025
• Camp4 Therapeutics Files 8-K — 8-K · May 16, 2025
• Camp4 Therapeutics Files Q1 2025 10-Q — 10-Q · May 13, 2025
• Camp4 Therapeutics Files Proxy Statement for 2025 Meeting — DEF 14A · Apr 30, 2025
• Camp4 Therapeutics CORP 10-K Filing — 10-K · Mar 27, 2025
• Camp4 Therapeutics Corp. Announces CSO Departure, Director Changes — 8-K · Mar 18, 2025
• Camp4 Therapeutics CORP 8-K Filing — 8-K · Jan 7, 2025